While coverage of Lucentis to treat the wet form of age related macular degeneration has been recommended for UK residents by the National Institute of Clinical Instutute (NICE), people are still being denied treatment under the old criteria. Final decision on who should receive Lucentis treatment for free is expected in the next few months,